Yazen transforms the accessibility of obesity treatment
Yazen tackles the challenge with groundbreaking, accessible, and comprehensive treatment approach
Since the World Health Organization recognized obesity as a chronic disease back in 1997, it has only recently begun to be treated as such. Yazen, a Swedish healthcare service, tackles this challenge with a groundbreaking, accessible, and comprehensive treatment approach.
By focusing on the hormonal imbalance that causes obesity, Yazen offers medical treatments that work in conjunction with lifestyle changes, guided by a team of health experts. With their new treatment philosophy and an innovative digital platform, Yazen paves the way for more preventive care and hope for a healthier future for patients across Sweden – and soon, the world over.
Read full article on Näringsliv.se (page 7)
More news
Yazen achieved record-breaking growth in 2025, doubling its revenue.
In 2025, Yazen's revenue surged 87% to nearly €29.4 million, with gross profits doubling to €16.5 million. Now treating over 37,000 active patients across seven countries, the company is eyeing further expansion into two more markets in 2026. Despite an EBITDA of –€5.7 million due to heavy growth investment, Yazen remains a leader in European obesity care.
